147 related articles for article (PubMed ID: 12964499)
1. Impact of CagA status on serum gastrin and pepsinogen I and II concentrations in Japanese children with Helicobacter pylori infection.
Fukuda Y; Isomoto H; Ohnita K; Omagari K; Mizuta Y; Murase K; Murata I; Moriuchi H; Kohno S
J Int Med Res; 2003; 31(4):247-52. PubMed ID: 12964499
[TBL] [Abstract][Full Text] [Related]
2. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
[TBL] [Abstract][Full Text] [Related]
4. Serum gastrin and pepsinogen I, II concentrations in children with Helicobacter pylori infection: the role of CagA and VacA.
Kim JW; Chung KS
Yonsei Med J; 1998 Apr; 39(2):159-65. PubMed ID: 9587257
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
[TBL] [Abstract][Full Text] [Related]
6. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
[TBL] [Abstract][Full Text] [Related]
7. Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma.
Elias N; Nasrallah E; Khoury C; Mansour B; Abu Zuher L; Asato V; Muhsen K
Pediatr Pulmonol; 2020 Sep; 55(9):2236-2245. PubMed ID: 32543787
[TBL] [Abstract][Full Text] [Related]
8. Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.
Shiota S; Murakami K; Okimoto T; Kodama M; Yamaoka Y
J Gastroenterol Hepatol; 2014 Jan; 29(1):67-73. PubMed ID: 24033876
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
[TBL] [Abstract][Full Text] [Related]
11. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
12. Screening of precancerous gastric lesions by serum pepsinogen, gastrin-17, anti-helicobacter pylori and anti- CagA antibodies in dyspeptic patients over 50 years old in Guilan Province, north of Iran.
Mansour-Ghanaei F; Joukar F; Rajpout Y; Hasandokht T
Asian Pac J Cancer Prev; 2014; 15(18):7635-8. PubMed ID: 25292040
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients.
Takamura A; Ito M; Imagawa S; Takata S; Tanaka S; Teixeira CR; Kamada T; Haruma K; Chayama K
Scand J Gastroenterol; 2011 Sep; 46(9):1051-6. PubMed ID: 21736532
[TBL] [Abstract][Full Text] [Related]
14. Association between serum pepsinogen A and C levels, serum gastrin concentrations and Helicobacter pylori antibodies.
Kullich W; Pöllmann G; Czerwenka C; Klein G
Wien Med Wochenschr; 1999; 149(7):157-61. PubMed ID: 10413837
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of pepsinogen I, pepsinogen II, and gastrin-17 in the course of Helicobacter pylori gastritis in pediatrics.
Kalach N; Legoedec J; Wann AR; Bergeret M; Dupont C; Raymond J
J Pediatr Gastroenterol Nutr; 2004 Nov; 39(5):568-9. PubMed ID: 15572903
[No Abstract] [Full Text] [Related]
16. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
[TBL] [Abstract][Full Text] [Related]
17. Serological comparison of serum pepsinogen and anti-parietal cell antibody levels between Japanese and German patients.
Ito M; Haruma K; Kaya S; Kamada T; Kim S; Sasaki A; Sumii M; Tanaka S; Yoshihara M; Wagner S; Chayama K
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):123-7. PubMed ID: 11981335
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus is characterized by the absence of Helicobacter pylori infection and high levels of serum pepsinogen I concentration in Japan.
Abe Y; Iijima K; Koike T; Asanuma K; Imatani A; Ohara S; Shimosegawa T
J Gastroenterol Hepatol; 2009 Jan; 24(1):129-34. PubMed ID: 19196398
[TBL] [Abstract][Full Text] [Related]
19. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
[TBL] [Abstract][Full Text] [Related]
20. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
